V. Lima

J. Montaner, G. Bondy, M. Harris, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Social Isolation and Mortality Among People Living with HIV in British Columbia, Canada

R. Hogg, K. Card, Lu Wang, 2020, AIDS and Behavior.

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada

B. Gazzard, C. Leen, B. Yip, 2017, HIV medicine.

Cohort Profile: HAART Observational Medical Evaluation and Research (HOMER) cohort.

P. Harrigan, B. Yip, R. Hogg, 2015, International journal of epidemiology.

Declines in highly active antiretroviral therapy initiation at CD4 cell counts ≤ 200 cells/μL and the contribution of diagnosis of HIV at CD4 cell counts ≤ 200 cells/μL in British Columbia, Canada

R. Hogg, D. Moore, R. Barrios, 2015, HIV medicine.

Modeling scenarios for the end of AIDS.

J. Kahn, A. Whiteside, J. Saavedra, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effect of Baseline CD4 Cell Counts on the Clinical Significance of Short-Term Immunologic Response to Antiretroviral Therapy in Individuals With Virologic Suppression

Ross J. Harris, J. Sterne, A. Mocroft, 2009, Journal of acquired immune deficiency syndromes.

Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy

Jessie K. Edwards, Richard D Moore, S. Cole, 2021, AIDS.

The effect of history of injection drug use and alcoholism on HIV disease progression

R. Hogg, J. Montaner, E. Wood, 2014, AIDS care.

The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART

T. Patterson, R. Hogg, J. Montaner, 2007, AIDS.

Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.

Andrea D. Olmstead, O. Pybus, P. Harrigan, 2016, Journal of hepatology.

Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years.

Richard D Moore, Jennifer S. Lee, S. Cole, 2020, The Journal of infectious diseases.

Overdose mortality is reducing the gains in life expectancy of antiretroviral-treated people living with HIV in British Columbia, Canada.

T. Patterson, W. Honer, R. Hogg, 2021, The International journal on drug policy.

Non-R5-tropic HIV-1 in subtype A1 and D infections were associated with lower pretherapy CD4+ cell count but not with PI/(N)NRTI therapy outcomes in Mbarara, Uganda

Jeffrey N. Martin, P. Harrigan, A. R. Mocello, 2016, AIDS.

Trends in AIDS incidence and AIDS-related mortality in British Columbia between 1981 and 2013

B. Yip, R. Hogg, J. Montaner, 2015 .

The determinants of poor respiratory health status in adults living with human immunodeficiency virus infection.

J. Leipsic, J. Montaner, D. Sin, 2014, AIDS patient care and STDs.

“The way I see it”: the effect of stigma and depression on self-perceived body image among HIV-positive individuals on treatment in British Columbia, Canada

R. Hogg, J. Montaner, A. Palmer, 2011, AIDS care.

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years

J. Singer, J. Montaner, Zunyou Wu, 2014, Journal of the International AIDS Society.

Retention in care and mortality trends among patients receiving comprehensive care for HIV infection: a retrospective cohort study.

B. Yip, J. Montaner, R. Barrios, 2019, CMAJ open.

Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, Canada

J. Montaner, Lu Wang, P. Sereda, 2022, AIDS.

Estimation of time of HIV seroconversion using a modified CD4 depletion model.

J. Montaner, Lu Wang, P. Sereda, 2021, PloS one.

Disability-adjusted life years associated with chronic comorbidities among people living with and without HIV: Estimating health burden in British Columbia, Canada

J. Kopec, R. Hogg, J. Montaner, 2022, PLOS global public health.

Relative effects of antiretroviral therapy and harm reduction initiatives on HIV incidence in British Columbia, Canada, 1996-2013: a modelling study.

P. Harrigan, J. Montaner, E. Wood, 2017, The lancet. HIV.

Use of Gay Chatlines and Online Dating Platforms as Potential Mediators or Moderators in the Relationship Between Loneliness, Self-Rated Attractiveness and Human Immunodeficiency Virus Acquisition Risk Among Gay, Bisexual, and Other Men Who Have Sex With Men in Vancouver, Canada

R. Hogg, D. Moore, N. Lachowsky, 2022, Sexually transmitted diseases.

Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada

Richard D Moore, J. Margolick, S. Gange, 2020, Journal of the International AIDS Society.

Factors behind HIV testing practices among Canadian Aboriginal peoples living off-reserve

Kimberly A. Fernandes, R. Hogg, A. Anema, 2010, AIDS care.

Reductions in all‐cause and cause‐specific mortality among HIV‐infected individuals receiving antiretroviral therapy in British Columbia, Canada: 2001–2012

B. Yip, R. Hogg, D. Moore, 2016, HIV medicine.

The Association Between Food Insecurity and Mortality Among HIV-Infected Individuals on HAART

Kimberly A. Fernandes, R. Hogg, J. Montaner, 2009, Journal of acquired immune deficiency syndromes.

Exploring the live birth rates of women living with HIV in British Columbia, Canada

D. Money, A. Albert, E. Maan, 2019, PloS one.

A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders

W. Honer, J. Montaner, F. Vila-Rodriguez, 2022, AIDS (London).

Is there a rural/urban gap in the quality of HIV care for treatment-naïve HIV-positive individuals initiating antiretroviral therapy in British Columbia?

B. Yip, R. Hogg, J. Montaner, 2017, AIDS care.

The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs.

J. Montaner, E. Wood, Libo Li, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada

T. Patterson, R. Hogg, J. Montaner, 2012, PloS one.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

Love with HIV: A Latent Class Analysis of Sexual and Intimate Relationship Experiences Among Women Living with HIV in Canada

S. Trottier, T. Hart, R. Hogg, 2019, Archives of Sexual Behavior.

Weight gain among treatment-naïve persons with HIV starting integrase inhibitors compared to non-nucleoside reverse transcriptase inhibitors or protease inhibitors in a large in

Jun Yu Li, J. Margolick, S. Gange, 2020 .

Temporal trends in the discontinuation of first-line antiretroviral therapy.

B. Yip, R. Hogg, R. Harrigan, 2014, The Journal of antimicrobial chemotherapy.

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART

R. Hogg, J. Montaner, M. Daniel, 2006, AIDS research and therapy.

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Ross J. Harris, J. Sterne, A. Mocroft, 2008, The Lancet.

HIV Incidence and Prevalence Among Aboriginal Peoples in Canada

R. Hogg, J. Montaner, M. Murray, 2010, AIDS and Behavior.

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy

B. Yip, R. Hogg, J. Montaner, 2017, BMC Infectious Diseases.

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

Ross J. Harris, J. Sterne, A. Mocroft, 2008, The Lancet.

Differential impact of adherence on long-term treatment response among naive HIV-infected individuals

R. Hogg, J. Montaner, D. Moore, 2008, AIDS.

A Latent Class Analysis of the Social Determinants of Health Impacting Heavy Alcohol Consumption Among Women Living with HIV in Canada: The Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, A. Burchell, 2019, AIDS and Behavior.

Characterizing retention in HAART as a recurrent event process: insights into ‘cascade churn’

Jeong Eun Min, Bohdan Nosyk, J. Montaner, 2015, AIDS.

Costs of Health Resource Utilization Among HIV-Positive Individuals in British Columbia, Canada: Results From a Population-Level Study

B. Yip, R. Hogg, J. Montaner, 2015, PharmacoEconomics.

Process Monitoring of an HIV Treatment as Prevention Program in British Columbia, Canada

R. Hogg, J. Montaner, M. Gilbert, 2014, Journal of acquired immune deficiency syndromes.

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting

P. Harrigan, B. Yip, R. Hogg, 2014, PloS one.

Reply to 'Evidence is still required for treatment as prevention for riskier routes of HIV transmission'

P. Gustafson, A. Levy, R. Hogg, 2010 .

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic.

A. Levy, P. Harrigan, R. Hogg, 2008, The Journal of infectious diseases.

Silent mutations are selected in HIV-1 reverse transcriptase and affect enzymatic efficiency

B. Wynhoven, A. Poon, N. Sluis-Cremer, 2008, AIDS.

N348I in the Connection Domain of HIV-1 Reverse Transcriptase Confers Zidovudine and Nevirapine Resistance

B. Wynhoven, Mark Zanin, N. Sluis-Cremer, 2007, PLoS medicine.

Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012

R. Hogg, J. Montaner, D. Moore, 2017, BMC Infectious Diseases.

The Impact of Treatment as Prevention on the HIV Epidemic in British Columbia, Canada

R. Hogg, J. Montaner, P. Sereda, 2020, Current HIV/AIDS Reports.

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection.

P. Harrigan, B. Yip, R. Hogg, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy

Evan Wood, P. Harrigan, B. Yip, 2007, AIDS.

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada

R. Hogg, J. Montaner, V. Lima, 2010, PloS one.

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART

P. Harrigan, B. Yip, R. Hogg, 2006, PLoS medicine.

The Combined Effect of Modern Highly Active Antiretroviral Therapy Regimens and Adherence on Mortality Over Time

B. Yip, R. Hogg, J. Montaner, 2009, Journal of acquired immune deficiency syndromes.

Risk of Viral Failure Declines With Duration of Suppression on Highly Active Antiretroviral Therapy Irrespective of Adherence Level

P. Harrigan, B. Yip, R. Hogg, 2010, Journal of acquired immune deficiency syndromes.

Epidemiology of treatment failure: a focus on recent trends

P. Harrigan, R. Hogg, J. Montaner, 2009, Current opinion in HIV and AIDS.

Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy.

P. Harrigan, B. Yip, R. Hogg, 2008, The Journal of infectious diseases.

Safety and Efficacy of Once-Daily Nevirapine Dosing: A Multicohort Study

B. Yip, R. Hogg, J. Montaner, 2009, Antiviral therapy.

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.

P. Harrigan, J. Montaner, J. Min, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Gender Inequities in Quality of Care among HIV-Positive Individuals Initiating Antiretroviral Treatment in British Columbia, Canada (2000–2010)

R. Hogg, J. Montaner, A. Carter, 2014, PloS one.

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

B. Yip, R. Hogg, J. Montaner, 2008, JAMA.

Lopinavir/Ritonavir Pharmacokinetics in a Substitution of High‐Dose Soft‐Gelatin Capsule to Tablet Formulation

J. Montaner, M. Harris, M. Hull, 2009, Journal of clinical pharmacology.

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis.

Sabine Yerly, Huldrych F Günthard, Deenan Pillay, 2009, The Lancet. Infectious diseases.

Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV

E. Gouws, B. Williams, V. Lima, 2011, Current HIV research.

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

Evan Wood, Kate Shannon, Thomas Kerr, 2010, The Lancet.

The WHOMEN’s Scale (Women’s HAART Optimism Monitoring and EvaluatioN Scale v.1) and the Association with Fertility Intentions and Sexual Behaviours Among HIV-Positive Women in Uganda

T. Patterson, R. Hogg, D. Bangsberg, 2009, AIDS and Behavior.

Social Determinants of Health and Retention in HIV Care Among Recently Incarcerated Women Living with HIV in Canada

S. Trottier, T. Hart, R. Hogg, 2019, AIDS and Behavior.

Association between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals.

P. Harrigan, B. Yip, R. Hogg, 2009, American journal of public health.

AssociationBetweenHIV-1RNALevelandCD4Cell CountAmongUntreatedHIV-InfectedIndividuals

P. Harrigan, B. Yip, R. Hogg, 2009 .

Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada.

Richard D Moore, T. Sterling, M. Gill, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.

B. Yip, R. Hogg, J. Montaner, 2014, The Lancet. Infectious diseases.

A Made in Canada Strategy to Stop HIV and AIDS

Julio S. G. Montaner, E. Wood, T. Kerr, 2010 .

Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50

J. Montaner, G. Bondy, M. Harris, 2017, BMJ Open Diabetes Research & Care.

Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration

J. Sterne, B. Yip, M. Gill, 2018, Journal of clinical medicine.

Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy

P. Harrigan, B. Yip, R. Hogg, 2012, PloS one.

Progress towards the United Nations 90‐90‐90 and 95‐95‐95 targets: the experience in British Columbia, Canada

R. Hogg, J. Montaner, P. Sereda, 2017, Journal of the International AIDS Society.

Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

P. Harrigan, B. Yip, R. Hogg, 2016, BMC Infectious Diseases.

ASSESSING THE RELATIONSHIP BETWEEN PHYSICIAN AVAILABILITY AND VIRAL LOAD SUPPRESSION IN BRITISH COLUMBIA.

J. Montaner, O. Amram, Lu Wang, 2018, The Canadian geographer. Geographe canadien.

Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States

E. Hyle, M. Horberg, P. Rebeiro, 2021, Annals of epidemiology.

Conditions for eradicating hepatitis C in people who inject drugs: A fibrosis aware model of hepatitis C virus transmission.

D. Coombs, I. Rozada, V. Lima, 2016, Journal of theoretical biology.

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?

J. Montaner, E. Wood, I. Rozada, 2015, PloS one.

Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients

P. Harrigan, B. Yip, R. Hogg, 2007, AIDS.

Incidence of diabetes mellitus among people living with and without HIV in British Columbia, Canada between 2001 and 2013: a longitudinal population-based cohort study

R. Hogg, P. Sereda, V. Lima, 2021, BMJ Open.

Excess burden of age-associated comorbidities among people living with HIV in British Columbia, Canada: a population-based cohort study

J. Kopec, R. Hogg, J. Montaner, 2021, BMJ Open.

Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy

R. Hogg, J. Montaner, D. Moore, 2019, Current medical research and opinion.

Physicians’ patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting

B. Yip, R. Hogg, J. Montaner, 2019, BMJ Open.

Innovative Multimodal Training Program for Family Physicians Leads to Positive Outcomes Among Their HIV-Positive Patients

Z. Cui, R. Barrios, V. Lima, 2018, The Journal of continuing education in the health professions.

Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada

R. Hogg, J. Montaner, S. Lear, 2018, BMJ Open.

Health-adjusted life expectancy in HIV-positive and HIV-negative men and women in British Columbia, Canada: a population-based observational cohort study.

R. Hogg, J. Montaner, A. Justice, 2017, The lancet. HIV.

Heightened epidemic in men who have sex with men in Brazil.

R. Hogg, J. Montaner, N. Lachowsky, 2016, The lancet. HIV.

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function

B. Yip, R. Hogg, J. Montaner, 2016, Journal of the International AIDS Society.

Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes

P. Harrigan, R. Hogg, J. Montaner, 2015, AIDS.

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada

R. Hogg, J. Montaner, V. Lima, 2015, Journal of the International AIDS Society.

High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada

J. Montaner, B. Nosyk, V. Lima, 2014, PloS one.

CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC)

J. Sterne, P. Reiss, T. Sterling, 2017, Clinical Infectious Diseases.

Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio

J. Sterne, A. d’Arminio Monforte, P. Reiss, 2018, AIDS.

Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada

W. Honer, J. Montaner, A. Thornton, 2020, PLoS medicine.

High Prevalence of Carotid Plaque Identified Using Standard Carotid Ultrasound Techniques in HIV-Positive Patients with Low to Moderate Vascular Risk

J. Montaner, G. Bondy, V. Lima, 2014 .

Sexual Anxiety Among Women Living with HIV in the Era of Antiretroviral Treatment Suppressing HIV Transmission

S. Trottier, T. Hart, A. Burchell, 2020, Sexuality Research and Social Policy.

Prevalence and incidence of hepatitis C infection amongst men who have sex with men in a population‐based pre‐exposure prophylaxis program in British Columbia, Canada

J. Montaner, D. Moore, N. Lachowsky, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Intergenerational Sex as a Risk Factor for HIV Among Young Men Who Have Sex with Men: A Scoping Review

R. Hogg, J. Montaner, A. Anema, 2013, Current HIV/AIDS Reports.

Validating a self-report measure of HIV viral suppression: an analysis of linked questionnaire and clinical data from the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study

S. Trottier, T. Hart, R. Hogg, 2017, BMC Research Notes.

Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada

J. Montaner, D. Moore, Nicanor Bacani, 2023, PloS one.

Expanded Highly Active Antiretroviral Therapy Coverage - A Powerful Strategy to Curb Progression to AIDS, Death and New Infections.

A. Levy, J. Montaner, A. Anema, 2009, European infectious disease.

Quantifying the effect of health status on health care utilization using a preference-based health measure.

J. Kopec, V. Lima, 2005, Social science & medicine.

Correction: The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model

J. Montaner, A. Spaulding, C. Beckwith, 2015, PloS one.

The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.

J. Montaner, Huiru Dong, E. Wood, 2015, Drug and alcohol dependence.

Impact of personality disorders on leaving hospital against medical advice among people living with HIV in British Columbia, Canada

J. Montaner, R. Barrios, Ashok Krishnamoorthy, 2019, Social Psychiatry and Psychiatric Epidemiology.

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach

P. Harrigan, J. Montaner, J. Raghwani, 2018, Journal of viral hepatitis.

Examining the evidence on the causal effect of HAART on transmission of HIV using the Bradford Hill criteria

T. Patterson, J. Montaner, D. Havlir, 2013, AIDS.

The causal effect of opioid substitution treatment on HAART medication refill adherence

B. Yip, J. Montaner, E. Wood, 2015, AIDS.

Establishing the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS): Operationalizing Community-based Research in a Large National Quantitative Study

S. Trottier, T. Hart, R. Hogg, 2016, BMC Medical Research Methodology.

Discrimination And Calibration Of The Vacs Index 2.0 For Predicting Mortality Among People With Hiv In North America.

Richard D Moore, S. Gange, A. Justice, 2021, Clinical Infectious Diseases.

Characterizing durations of heroin abstinence in the California Civil Addict Program: results from a 33-year observational cohort study.

Bohdan Nosyk, Yih-Ing Hser, Mary-Lynn Brecht, 2013, American journal of epidemiology.

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification

P. Harrigan, J. Montaner, Lu Wang, 2017, PloS one.

Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.

P. Harrigan, J. Montaner, B. Marshall, 2015, Drug and alcohol dependence.

Adverse drug reactions to integrase strand transfer inhibitors

B. Yip, J. Montaner, Lu Wang, 2018, AIDS.

Does ratifi cation of human-rights treaties have eff ects on population health ?

Kimberly A. Fernandes, G. Guyatt, N. Ford, 2009 .

Identifying Longitudinal CD4:CD8 Ratio Trajectories Indicative of Chronic Renal Disease Risk among People Living with HIV: An Application of Growth Mixture Models

J. Montaner, Lu Wang, R. Barrios, 2023, Viruses.

A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study

J. Montaner, Lu Wang, R. Barrios, 2022, CMAJ open.

HIV-1 Disease Progression During Highly Active Antiretroviral Therapy: An Application Using Population-Level Data in British Columbia: 1996–2011

B. Yip, R. Hogg, J. Montaner, 2013, Journal of acquired immune deficiency syndromes.

Disparities in the Burden of HIV/AIDS in Canada

R. Hogg, J. Montaner, E. Wood, 2012, PloS one.

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

P. Harrigan, B. Yip, J. Joy, 2019, Open forum infectious diseases.

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

P. Harrigan, B. Yip, J. Montaner, 2017, AIDS.

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future

J. Montaner, C. Cohen, B. Nosyk, 2012, AIDS research and treatment.

Mortality Among Persons Entering HIV Care Compared With the General U.S. Population

Jessie K. Edwards, Richard D Moore, S. Cole, 2021, Annals of Internal Medicine.

Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay

J. Montaner, R. Harrigan, V. Lima, 2009, Journal of acquired immune deficiency syndromes.

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay

B. Yip, J. Montaner, B. Wynhoven, 2012, PloS one.

The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model

J. Montaner, A. Spaulding, C. Beckwith, 2015, PloS one.

The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum

P. Zandi, M. Horberg, P. Rebeiro, 2022, AIDS.

Healthcare utilisation and costs associated with adherence to antipsychotics among people living with HIV/AIDS and schizophrenia: a population-based cohort study in British Columbia, Canada

T. Patterson, W. Honer, J. Montaner, 2023, BMJ Open.

Sexual minority status modifies the association between HIV risk behavior and prevalent mood or anxiety disorders in British Columbia, Canada

T. Patterson, R. Hogg, K. Card, 2021, Social Psychiatry and Psychiatric Epidemiology.

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study

B. Yip, R. Hogg, J. Montaner, 2018, BMC Health Services Research.

Prevalence and clinical impacts of HIV-1 intersubtype recombinants in Uganda revealed by near-full-genome population and deep sequencing approaches

Jeffrey N. Martin, P. Harrigan, M. Siedner, 2017, AIDS.

Assessing the effectiveness of antiretroviral regimens in cohort studies involving HIV-positive injection drug users

J. Montaner, E. Wood, B. Nosyk, 2012, AIDS.

Long-term trends in CD4 cell counts, CD8 cell counts, and the CD4: CD8 ratio: ART Cohort Collaboration (ART-CC) Study.

J. Sterne, P. Reiss, T. Sterling, 2018, AIDS.

CD 4 : CD 8 Ratio and CD 8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy : The Antiretroviral Therapy Cohort Collaboration ( ARTCC )

J. Sterne, P. Reiss, T. Sterling, 2017 .

Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply.

P. Harrigan, B. Yip, R. Hogg, 2008, AIDS (London).

Presenting plasma HIV RNA level and rate of CD4 T-cell decline.

R. Hogg, J. Montaner, V. Lima, 2007, JAMA.

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings

J. Montaner, P. Harrigan, M. Hull, 2016, Journal of the International AIDS Society.

Longitudinal trends of HIV drug resistance in a large Canadian cohort, 1996-2016.

P. Harrigan, J. Shoveller, C. Brumme, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study

R. Hogg, J. Montaner, R. Barrios, 2015, BMC Health Services Research.

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada

J. Montaner, D. Moore, I. Rozada, 2019, EClinicalMedicine.

Epidemiology of antiretroviral multiclass resistance.

P. Harrigan, B. Yip, R. Hogg, 2010, American journal of epidemiology.

The 'Expanded HIV care in opioid substitution treatment' (EHOST) cluster-randomized, stepped-wedge trial: A study protocol.

J. Montaner, E. Wood, E. Krebs, 2015, Contemporary clinical trials.

Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.

J. Montaner, B. Williams, R. Granich, 2013, The Journal of infectious diseases.

Overrepresentation of Injection Drug Use Route of Infection Among Human Immunodeficiency Virus Long-term Nonprogressors: A Nationwide, Retrospective Cohort Study in China, 1989–2016

R. Brookmeyer, R. Detels, J. Montaner, 2019, Open forum infectious diseases.

Regional and temporal changes in HIV-related mortality in British Columbia, 1987-2006.

R. Hogg, J. Montaner, K. Muldoon, 2010, Canadian journal of public health = Revue canadienne de sante publique.

Dynamics of overdose and non-overdose mortality among people living with HIV amidst the illicit drug toxicity crisis in British Columbia.

R. Hogg, J. Montaner, Audrey Tung, 2023, AIDS Care.

The impact of lookback windows on the prevalence and incidence of chronic diseases among people living with HIV: an exploration in administrative health data in Canada

J. Kopec, R. Hogg, J. Montaner, 2022, BMC Medical Research Methodology.

"Test-and-treat" strategy for control of HIV and AIDS can lead to a decrease, not an increase, of multidrug-resistant viruses.

P. Harrigan, J. Montaner, C. Brumme, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada.

Jessie K. Edwards, Richard D Moore, S. Cole, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

B. Yip, R. Hogg, J. Montaner, 2008, JAMA.

J. Montaner, B. Nosyk, J. Montaner, 2016, HIV medicine.

Factors Predictive of 30-Day Postoperative Mortality in HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy

S. Wiseman, B. Yip, R. Hogg, 2012, Annals of surgery.

Correlates of social isolation among people living with HIV in British Columbia, Canada

R. Hogg, K. Card, Lu Wang, 2020, AIDS care.

Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients.

Kimberly A. Fernandes, R. Hogg, B. Rachlis, 2009, Social science & medicine.

Estimating the Impact of Earlier ART Initiation and Increased Testing Coverage on HIV Transmission among Men Who Have Sex with Men in Mexico using a Mathematical Model

C. del Rio, M. A. Colchero, S. Bautista-Arredondo, 2015, PloS one.

CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018.

Richard D Moore, Jennifer S. Lee, K. Buchacz, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018

Richard D Moore, Jennifer S. Lee, Jeffrey N. Martin, 2020, Clinical Infectious Diseases.

Disparities in multimorbidity and mortality among people living with and without HIV across British Columbia’s health regions: a population-based cohort study

J. Kopec, R. Hogg, J. Montaner, 2021, Canadian Journal of Public Health.

An assessment of the relationship between the World Health Organization HIV drug resistance early warning indicators and HIV drug resistance acquisition

P. Harrigan, P. Sereda, J. Montaner, 2017, HIV medicine.

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future

J. Montaner, C. Cohen, B. Nosyk, 2012, AIDS research and treatment.

"Test-and-treat" strategy for control of HIV and AIDS can lead to a decrease, not an increase, of multidrug-resistant viruses.

P. Harrigan, J. Montaner, C. Brumme, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

P762 TEMPORAL CHANGES IN HEPATITIS C VIRUS GENOTYPE 3A DISTRIBUTION AMONG PEOPLE WHO INJECT DRUGS IN VANCOUVER, CANADA

J. Montaner, J. Joy, G. Dore, 2014 .

Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

B. Yip, R. Hogg, J. Montaner, 2008, JAMA.

Regional and Temporal Trends in Migration among People Living with HIV/AIDS in British Columbia, 1993-2005

R. Hogg, J. Montaner, V. Lima, 2010 .

Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada

R. Hogg, J. Montaner, D. Moore, 2023, PloS one.

Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine.

Jessie K. Edwards, M. Hudgens, A. Adimora, 2023, American journal of epidemiology.

Evaluation of treatment tolerability, satisfaction and laboratory parameters in HIV+ patients switching from ritonavir capsule to tablet formulation.

R. Hogg, J. Montaner, M. Harris, 2013, Current HIV research.

Household food insecurity, sense of community belonging, and access to a regular medical doctor as mediators in the relationship between mood and/or anxiety disorders and self-rated general health in Canada between 2011 and 2016: a serial cross-sectional analysis

D. Moore, Hiwot M. Tafessu, V. Lima, 2022, Canadian Journal of Public Health.

A co-interaction model of HIV and syphilis infection among gay, bisexual and other men who have sex with men

F. Brauer, J. David, V. Lima, 2020, Infectious Disease Modelling.

Increased Reporting of Detectable Plasma HIV-1 RNA Levels at the Critical Threshold of 50 Copies per Milliliter With the Taqman Assay in Comparison to the Amplicor Assay

J. Montaner, R. Harrigan, V. Lima, 2009, Journal of acquired immune deficiency syndromes.

Regional and temporal trends in migration among people living with HIV/AIDS in British Columbia, 1993-2005.

R. Hogg, J. Montaner, V. Lima, 2010, Canadian journal of public health = Revue canadienne de sante publique.